About

Publications While At HealthPartners

selected publications

Journal Article

Effect of intrawound vancomycin powder in operatively treated high-risk tibia fractures: a randomized clinical trial. 

JAMA surgery. 2021

Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study. 

Lancet Oncology. 2018

Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer. 

New England Journal of Medicine. 2017

Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial. 

Lancet Oncology. 2016

Biomarker-calibrated dietary energy and protein intake associations with diabetes risk among postmenopausal women from the Women's Health Initiative. 

American Journal of Clinical Nutrition. 2011

Contact

full name

Y. Huang

Quick Info

 

Collaboration

Co-author network

Map of science